Sukumar Nagendran - President and Head of R&D, Director at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Head of R&D, Director
Issuer Symbol
TSHA on Nasdaq
All Insider Reports
All Insider Reports

Sukumar Nagendran - trading volume in the past year for Taysha Gene Therapies, Inc.

Holdings reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,317,389 $6,073,163 $4.61 26 Jan 2026 Direct
Employee Stock Option (right to buy) 274,000 12 Jan 2026 Direct Common Stock

Transactions reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.